Back
Blackrock Munivest Fund II Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
47
MVT
Blackrock Munivest Fund II
Last Price:
$9.91
Seasonality Move:
-2.54%
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
$14.08
Seasonality Move:
29.39%
Sell
47
Blackrock Munivest Fund II (MVT)
is a Sell
Is Blackrock Munivest Fund II a Buy, Sell or Hold?
-
The current Blackrock Munivest Fund II [MVT] share price is $9.90. The Score for MVT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
MVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $14.08. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MVT Stock Price Chart
What is Blackrock Munivest Fund II's stock price today?
-
The Blackrock Munivest Fund II share price today is $9.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MVT is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $14.08The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
MVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.8 | Buy |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -64818 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.08 - 10.28) | Sell |
Bollinger Bands (100): | (10.03 - 10.61) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.01 | Buy |
Relative Strength Index (14 RSI): | 30.81 | Sell |
Chaikin Money Flow: | -47284273 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.93 - 25.27) | Sell |
Bollinger Bands (100): | (23.99 - 79.25) | Sell |
MVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.14 | Sell |
20-day SMA: | 10.19 | Sell |
50-day SMA: | 10.18 | Sell |
200-day SMA: | 10.63 | Sell |
8-day EMA: | 9.04 | Buy |
20-day EMA: | 6.01 | Buy |
50-day EMA: | 3.07 | Buy |
200-day EMA: | 0.87 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.56 | Sell |
20-day SMA: | 18.29 | Sell |
50-day SMA: | 29.07 | Sell |
200-day SMA: | 86.06 | Sell |
8-day EMA: | 16.26 | Sell |
20-day EMA: | 10.95 | Buy |
50-day EMA: | 5.61 | Buy |
200-day EMA: | 1.6 | Buy |
Blackrock Munivest Fund II Earnings Growth & MVT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $1.02 per share, a decrease this year of $6.30 per share, and an increase next year of $6.46 per share.
Blackrock Munivest Fund II Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |